Note: Ingredients listed on restricted chemical lists
EC/CAS
618-561-0/9046-10-0
Name of the chemical
Poly(propyleneglycol)diamine
Concentration
≥10-<20 ≥1-<2.5
General Information
Revision date
2022-11-29
Product name
MAPEPOXY CEM-S /B
Emergency telephone
+47 22591300
Icons in SDS
Company Information
company name
Mapei Oy
e-mail address of the competent person responsible for the Safety Data Sheet
info@mapei.fi, sicurezza@mapei.it
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No other hazards
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P261 Avoid breathing mist/vapours/spray. P264 Wash hands thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/clothing and eye/face protection. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P337+P313 If eye irritation persists: Get medical advice/attention.
Special Provisions
EUH208
Contains
Amines, polyethylenepoly-, tetraethylenepentamine fraction. May produce an allergic reaction Print date 29/11/2022 Production Name MAPEPOXY CEM-S /B Page n. 1 of Formaldehyde, polymer with N1-(2- aminoethyl)-N2-[2-[(2- aminoethyl)amino]ethyl]-1,2- ethanediamine, 2,2'-[1,4-butanediylbis (oxymethylene)]bis[oxirane], 4,4'-(1- methylethylidene) bis(4,1- phenyleneoxymethylene)bis[oxirane], reaction products with Bu glycidylether and 1-[[2-(2-aminoethyl) ethyl]amino]- 3- phenoxy-2-propanol, acetates (salts)
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
None.
2.3 Other hazards
No PBT, vPvB or endocrine disruptor substances present in concentration >= 0.1%. No other hazards
